TLS Advisors LLC
- SEC CIK
- 0001768824
- 最新申報
- 2026/8/14
2022 年第 4 季持倉
持倉截至 2022/12/31，2023/2/14 申報。只含多頭部位。
- 持股檔數
- 21
- 2022 年第 3 季沒有申報
- 總值
- $2,029 萬
- 2022 年第 3 季沒有申報
TLS Advisors LLC 沒有申報 2022 年第 3 季的 13F，這一季的持倉沒辦法跟上一季比較，所以不顯示股數變化與動作。
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| EQTEQT Corp | Stock | 150,800 | $510.2 萬 | 25.1% | – | – | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 1,490,534 | $277.2 萬 | 13.7% | – | – | 歷史 |
| XOMAXOMA Royalty Corp | COM NEW | 124,024 | $228.2 萬 | 11.2% | – | – | 歷史 |
| METAMeta Platforms, Inc. | Stock | 14,589 | $175.6 萬 | 8.7% | – | – | 歷史 |
| OABIOmniAb, Inc. | COM | 386,592 | $139.2 萬 | 6.9% | – | – | 歷史 |
| SICPSilvergate Capital Corp | CL A | 79,795 | $138.8 萬 | 6.8% | – | – | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 33,756 | $133.1 萬 | 6.6% | – | – | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 125,731 | $103.4 萬 | 5.1% | – | – | – |
| TSLATesla, Inc. | Stock | 6,000 | $73.9 萬 | 3.6% | – | – | 歷史 |
| LITSLite Strategy, Inc. | COM NEW | 2,010,285 | $49.0 萬 | 2.4% | – | – | 歷史 |
| FSTXF-star Therapeutics, Inc. | COM | 54,298 | $34.3 萬 | 1.7% | – | – | 歷史 |
| NBISNebius Group N.V. | Stock | 17,811 | $33.7 萬 | 1.7% | – | – | 歷史 |
| HOVHovnanian Enterprises Inc | CL A NEW | 6,472 | $27.2 萬 | 1.3% | – | – | 歷史 |
| iShares Inc46434G780 | MSCI SINGPOR ETF | 13,600 | $25.5 萬 | 1.3% | – | – | – |
| Affimed N VN01045108 | COM | 161,971 | $20.1 萬 | 1.0% | – | – | – |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 250 | $18.0 萬 | 0.9% | – | – | 歷史 |
| NKTXNkarta, Inc. | COM | 26,842 | $16.1 萬 | 0.8% | – | – | 歷史 |
| RRCRange Resources Corp | COM | 59,823 | $15.0 萬 | 0.7% | – | – | 歷史 |
| APTOAptose Biosciences Inc. | COM NEW | 89,403 | $5.20 萬 | 0.3% | – | – | 歷史 |
| NNDMNano Dimension Ltd. | SPONSORD ADS NEW | 22,000 | $5.10 萬 | 0.3% | – | – | 歷史 |
| Kludein I Acquisition Corp49878L117 | *W EXP 07/08/202 | 10,000 | $1,000 | <0.1% | – | – | – |